Sergio
Ruiz Llorente
Profesor/a Ayudante Doctor/a


Instituto de Investigación Sanitaria de Navarra
Pamplona, España
Instituto de Investigación Sanitaria de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2025
-
Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 31, Núm. 9, pp. 1644-1656
2023
-
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
Frontiers in Immunology, Vol. 14